What Is Lung Cancer

Lung cancer is a type of cancer that begins in the lungs, specifically in the cells lining the air passages. It is one of the most common types of cancer and a leading cause of cancer-related deaths worldwide. According to the data from American Lung Association and American Cancer Society, an estimated over 238 thousand people will be diagnosed with lung cancer, and over 127 thousand people will die from it in 2023. Lung cancer is usually fatal because most cases are diagnosed at a late stage and treatment has generally been ineffective. Patients undergoing Next-Generation Sequencing (NGS) testing increased approximate 11 months of survival time compared to those who did not undergo sequencing.


Why Genetics Testing Is Important

Genetic testing is important for cancer treatment for several reasons:

1.Personalized Treatment Approaches:

Genetic testing can provide information about specific mutations or alterations in the tumor’s DNA. This information can help oncologists tailor treatment plans based on the unique genetic profile of the cancer. Some genetic mutations may respond better to certain targeted therapies, allowing for more effective and personalized treatment strategies.

  1. Predicting Treatment Response:

Genetic testing can help predict how a patient’s cancer is likely to respond to certain treatments. Understanding the genetic makeup of the tumor can guide the selection of chemotherapy agents or other targeted therapies that are more likely to be effective, potentially improving treatment outcomes.

  1. Clinical Trial Eligibility:

Genetic testing results may identify individuals who are eligible for participation in clinical trials studying new treatments or therapies specific to certain genetic mutations. Participation in clinical trials can provide access to cutting-edge treatments and contribute to advancements in colorectal cancer research.

In summary, genetic testing plays a crucial role in cancer treatment by providing valuable information about the genetic factors influencing the disease. This knowledge enables more personalized and targeted approaches to treatment, improves the prediction of treatment outcomes, and contributes to the overall management of the disease for both the patient and their family.

Gene on Link KF Lung Cancer NGS Test Information
General Infomation

Gene on Link laboratory use KimForest Lung Cancer Panel conduct NGS test for colorectal cancer. This panel is developed by KimForest, Taiwan and covers over 60% common gene mutations of colorectal cancer.

Gene on Link KF Lung Cancer NGS Test Information

Gene on Link KF Lung Cancer NGS Test Information
Report Content

Patient & Specimen Information

Test Result Summary

Clinical Implications

Biological Relevance of Detected Alterations


Specimen Quality

QC Record

Test Information

Report Statements

Gene on Link KF Lung Cancer NGS Test Information

*DNA isolation must be conducted in a CLIA-certified-laboratory or a laboratory meeting equivalent requirements as determined by the CAP or CMS.